DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
DexCom
DXCM
Hutchmed (China)
HCM
New Fortress Energy
NFE
Enerpac Tool
EPAC
US Stock MarketDetailed Quotes
CTMX CytomX
- 0.796
- -0.030-3.63%
Close Feb 14 16:00 ET
- 0.797
- +0.001+0.09%
Post 20:01 ET
62.32MMarket Cap4.98P/E (TTM)
0.844High0.788Low885.37KVolume0.827Open0.826Pre Close716.07KTurnover1.23%Turnover RatioLossP/E (Static)78.26MShares5.85052wk High-2.65P/B57.52MFloat Cap0.75052wk Low--Dividend TTM72.24MShs Float35.000Historical High--Div YieldTTM6.79%Amplitude0.750Historical Low0.808Avg Price1Lot Size
About CytomX Company
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.
Company Profile
SymbolCTMX
Company NameCytomX
Listing DateOct 8, 2015
Issue Price12.00
Founded2010
CEODr. Sean A. McCarthy, D.Phil.
MarketNASDAQ
Employees122
Fiscal Year Ends12-31
Address151 Oyster Point Boulevard,Suite 400
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080-1913
Phone1-605-515-3185
Websitehttp://www.cytomx.com
Company Executives
- Name
- Position
- Salary
- Dr. Sean A. McCarthy, D.Phil.
- Chief Executive Officer and Chairman of the Board
- 2.61M
- Marcia Belvin
- Senior Vice President and Chief Scientific Officer
- 1.21M
- Christopher W. Ogden
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Mani Mohindru, PhD
- Independent Director
- 78.62K
- Halley E. Gilbert
- Independent Director
- 80.62K
- Dr. Elaine V. Jones, PhD
- Independent Director
- 75.12K
- James R. Meyers
- Independent Director
- 77.12K
- Dr. Alan Ashworth
- Independent Director
- 69.12K
- Matthew P. Young
- Lead Independent Director
- 105.12K
- Dr. Zhen Su
- DIrector
- --